Tn-MUC1 DC Vaccine (Hamilton Health Sciences)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTn-MUC1 DC Vaccine (Hamilton Health Sciences)

Drug Alias NameTn-MUC1 glyco peptide-DC

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesHamilton Health Sciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHamilton Health Sciences

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A